Literature DB >> 1395101

Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance.

P Rumore1, B Muralidhar, M Lin, C Lai, C R Steinman.   

Abstract

The rate of clearance of extracellular plasma DNA in man has important implications for pathogenetic mechanisms in systemic lupus erythematosus (SLE), as well as for certain other clinical states. Present knowledge of this parameter is derived exclusively from studies of injected, naked DNA in animals. Recent information indicates that the physiologic form of plasma DNA in SLE is that of oligonucleosome-like molecules rather than of naked DNA and consists of multimeric complexes of DNA bound to histone, probably arising from an apoptotic process. In order to study the rate at which these oligonucleosome-like complexes are removed from plasma and to do so in man rather than experimental animals, we exploited the observation that during haemodialysis large amounts of DNA are released, apparently within the dialysis coil, into the patient's plasma. Since this release appears to cease promptly with termination of the procedure, it offered the potential for estimating the rate of removal of such DNA from human plasma. Moreover, if that DNA, as postulated, were shown to possess an oligonucleosome-like structure resembling that found endogenously in human SLE, the relevance of such information to the human disease state would be further enhanced. The present results support the conclusion that DNA released into plasma during haemodialysis possesses such an oligonucleosome-like structure. The plasma half-life of that DNA in man was found not to exceed 4 min. The highly dynamic state thus implied for extracellular endogenous plasma DNA in man has important implications for pathogenetic mechanisms dependent on dsDNA in SLE. Moreover, individuals undergoing chronic haemodialysis, who are thereby exposed to a very large cumulative amount of such DNA, might serve as models for studying its long-term sequelae.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1395101      PMCID: PMC1554541          DOI: 10.1111/j.1365-2249.1992.tb05831.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Circulating DNA in systemic lupus erythematosus. Association with central nervous system involvement and systemic vasculitis.

Authors:  C R Steinman
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

2.  DNA of free and complexed origin in human plasma: concentration and length distribution.

Authors:  R H Dennin
Journal:  Klin Wochenschr       Date:  1979-05-03

3.  In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.

Authors:  R P Taylor; G Kujala; K Wilson; E Wright; A Harbin
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

4.  The clearance and localization of nucleic acids by New Zealand and normal mice.

Authors:  T M Chused; A D Steinberg; N Talal
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

5.  Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate.

Authors:  F G Cosio; L A Hebert; D J Birmingham; B L Dorval; A P Bakaletz; G A Kujala; J C Edberg; R P Taylor
Journal:  Clin Immunol Immunopathol       Date:  1987-01

Review 6.  Apoptosis: cell death in tissue regulation.

Authors:  A H Wyllie
Journal:  J Pathol       Date:  1987-12       Impact factor: 7.996

Review 7.  Nucleosome structure.

Authors:  J D McGhee; G Felsenfeld
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  A prospective study of plasma DNA in the diagnosis of pulmonary embolism.

Authors:  J N Sipes; P M Suratt; C D Teates; F A Barada; J S Davis; C J Tegtmeyer
Journal:  Am Rev Respir Dis       Date:  1978-09

9.  Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes.

Authors:  C Morimoto; H Sano; T Abe; M Homma; A D Steinberg
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

10.  Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus.

Authors:  A McCoubrey-Hoyer; T B Okarma; H R Holman
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

View more
  18 in total

1.  Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus.

Authors:  S Zhong; M C Ng; Y M Lo; J C Chan; P J Johnson
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

2.  Comparison between plasma and whole blood specimens for detection of Aspergillus DNA by PCR.

Authors:  J Loeffler; H Hebart; U Brauchle; U Schumacher; H Einsele
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

3.  DNA methylation in circulating tumour DNA as a biomarker for cancer.

Authors:  Ruth E Board; Lucy Knight; Alastair Greystoke; Fiona H Blackhall; Andrew Hughes; Caroline Dive; Malcolm Ranson
Journal:  Biomark Insights       Date:  2008-01-25

Review 4.  CpG DNA: a pathogenic factor in systemic lupus erythematosus?

Authors:  A M Krieg
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

Review 5.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

6.  Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.

Authors:  Cornelia Lass-Flörl; Eberhard Gunsilius; Günther Gastl; Hugo Bonatti; Martin C Freund; Andreas Gschwendtner; Gabriele Kropshofer; Manfred P Dierich; Andreas Petzer
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

7.  Nucleosomes as a new prognostic marker in early cerebral stroke.

Authors:  Sandra Geiger; Stefan Holdenrieder; Petra Stieber; Gerhard F Hamann; Roland Bruening; Jun Ma; Dorothea Nagel; Dietrich Seidel
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

8.  Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.

Authors:  Carina Roth; Klaus Pantel; Volkmar Müller; Brigitte Rack; Sabine Kasimir-Bauer; Wolfgang Janni; Heidi Schwarzenbach
Journal:  BMC Cancer       Date:  2011-01-06       Impact factor: 4.430

9.  Elevated levels of cell-free circulating DNA in patients with acute dengue virus infection.

Authors:  Tran Thi Ngoc Ha; Nguyen Tien Huy; Lyre Anni Murao; Nguyen Thi Phuong Lan; Tran Thi Thuy; Ha Manh Tuan; Cao Thi Phi Nga; Vo Van Tuong; Tran Van Dat; Mihoko Kikuchi; Michio Yasunami; Kouichi Morita; Vu Thi Que Huong; Kenji Hirayama
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

10.  Verification of performance of a direct fluorescent assay for cell-free DNA quantification, stability according to pre-analytical storage conditions, and the effect of freeze-thawing.

Authors:  Jae-Joon Kim; Kwonoh Park; Yu Ran Han; Syed Hyun Kim; Sang-Bo Oh; So Yeon Oh; Yun Jeong Hong; Mi Sook Yun
Journal:  Biomed Rep       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.